Bhavana Chalupadi, Pharm D, R Ph
About Bhavana Chalupadi, Pharm D, R Ph
Bhavana Chalupadi, Pharm D, R Ph, is a Global Regulatory Manager at Bristol Myers Squibb with extensive experience in pharmacy practice and regulatory affairs.
Current Title and Role
Bhavana Chalupadi, Pharm D, R Ph, serves as the Global Regulatory Manager at Bristol Myers Squibb, based in Morristown, NJ. In this role, she is responsible for overseeing the regulatory aspects of the company’s drug development and ensuring compliance with global regulations.
Previous Professional Experience
Before joining Bristol Myers Squibb, Bhavana Chalupadi worked as a Medical Writer at RevHealth in Morristown, NJ, from 2020 to 2021. Prior to that, she contributed to public health efforts at the Massachusetts COVID-19 Testing Site in Lowell, MA, where she served as a Pharmacist for four months in 2020. Bhavana also has extensive experience as a Pharmacist at CVS Pharmacy in Dracut, MA, where she worked for six years from 2014 to 2020.
Education and Academic Background
Bhavana Chalupadi completed her Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices at Northeastern University. She holds a Doctor of Pharmacy (PharmD) and a Bachelor of Science in Pharmacy Studies from the University of Connecticut, where she studied from 2013 to 2019 and 2013 to 2017 respectively. She initially completed her high school education at Acton-Boxborough Regional High School from 2009 to 2013.
Expertise in Regulatory Affairs and Pharmacy
With over a decade in the pharmaceutical industry, Bhavana Chalupadi has developed a diverse skill set encompassing both regulatory management and medical writing. Her in-depth understanding of regulatory affairs for drugs, biologics, and medical devices is supported by advanced education and practical experience. She has a robust background in pharmacy practice, having served as a pharmacist for multiple years prior to her current role.
Pharmaceutical Industry Contributions
Bhavana Chalupadi’s role in the pharmaceutical industry has seen her make significant contributions, particularly during the COVID-19 pandemic where she was involved in testing initiatives. Her extensive experience across various roles underscores her comprehensive expertise and versatility within the field.